Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease

BACKGROUND: A high incidence of interstitial lung disease (ILD) has been reported in patients with advanced non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), particularly in Japanese populations. A previous report from our labora...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kawase, Shigeo, Hattori, Noboru, Ishikawa, Nobuhisa, Horimasu, Yasushi, Fujitaka, Kazunori, Furonaka, Osamu, Isobe, Takeshi, Miyoshi, Seigo, Hamada, Hironobu, Yamane, Takashi, Yokoyama, Akihito, Kohno, Nobuoki
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3160959/
https://ncbi.nlm.nih.gov/pubmed/21791074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-97
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares